Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Glycogen storage disease type II, Pompe disease - (AR) | 9.1 | | | Acid alpha-glucosidase preproprotein
|
|
| | * Limb-Girdle, Muscular dystrophy, type 2V - LGMD2V | | * Glycogen storage disease II - GSDII |
|
Glycogen storage disease type IIIa - (AR) | 9.2 | | | Amylo-1,6-glucosidase, 4-alpha-glucanotransferase
|
|
| | * Glycogen storage disease type IIIb - GSD IIIb | | * Glycogen storage disease type IIIa - GSD IIIa | | * Glycogen storage disease type IIId - GSD IIId | | * Glycogen storage disease type IIIc - GSD IIIc |
|
Glycogen storage disease type IV - (AR) | 9.3 | | | Glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV)
|
|
| | * Glycogen branching enzyme deficiency - GSD IV |
|
Glycogen storage disease Type V (McArdle) - (AR) | 9.4 | | | | * McArdle disease - PYGM |
|
Glycogen storage disease Type VII (Tarui) - (AR) | 9.5 | | | Phosphofructokinase, muscle
|
|
| | * Glycogen storage disease VII - PFKM |
|
Glycogen storage disease type IXd (ex type VIII) or muscle phosphorylase kinase defiency - (XR) | 9.6 | | | Phosphorylase b kinase, alpha submit
|
|
| | * glycogen storage disease, type IXD - GSD9D |
|
Glycogenosis type XIV - (AR) | 9.7 | | | | * Glycogen storage disease XIV - GSD14 |
|
Glycogenosis type XV - (AR) | 9.8 | | | | * Glycogen storage disease XV - GSD15 | | * Polyglucosan Body Myopathy 2 - PGBM2 |
|
Glycogen storage disease type 0 - (AR) | 9.9 | | | Glycogen synthase 3 glycogen synthase 1 (muscle) glycogen synthase 1 (muscle)
|
|
| | * glycogen storage disease type 0 - GSD0b |
|
Glycogen storage disease of heart, lethal congenital - (AD) | 9.10 | | | Protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
| | * Cardiomyopathy, familial hypertrophic, with Wolff-Parkinson-white syndrome - CMH6 | | * glycogen storage disease of heart, lethal congenital |
|
Polyglucosan storage myopathy - (AR) | 9.11 | | | RanBP-type and C3HC4-type zinc finger containing 1 (heme-oxidized IRP2 ubiquitin ligase 1)
|
|
| | * Polyglucosan Body Myopathy 1 with or without immunodeficiency - PGBM1 |
|
Polyglucosan Body Myopathy 2 - (AR) | 9.12 | | | | * Glycogen storage disease XV - GSD15 | | * Polyglucosan Body Myopathy 2 - PGBM2 |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Phosphoglycerate kinase 1 deficiency - (XR) | 9.13 | | | Phosphoglycerate kinase 1
|
|
| | * posphoglycerate kinase deficiency |
|
Glycogen storage disease type X - (AR) | 9.14 | | | Phosphoglycerate mutase 2 (muscle)
|
|
| | * Glycogen storage disease X - GSD10 | | * Myopathy due to phosphoglycerate mutase deficiency - PGAMM |
|
Glycogen storage disease type XI - (AR) | 9.15 | | | | * Glycogen storage disease XI - GSD11 | | * Exertional myoglobinuria due to deficiency of LDH-A - LDHA |
|
Glycogen storage disease type XIII - (AD) | 9.16 | | | Enolase 3, beta muscle specific
|
|
| | * Glycogen storage disease XIII - GSD13 | | * Enolase deficiency - ENO3 |
|
Erythrocyte lactate transporter defect (Myopathy due to actate transporter defect) - (AD) | 9.17 | | | Solute carrier family 16, member 1 (monocarboxylic acid transporter 1)
|
|
| | * Erythrocyte lactate transporter defect |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Carnitine palmitoyl-transferase II deficiency, myopathic, stress induced - (AD, AR) | 9.18 | | | Carnitine palmitoyltransferase II(M)
|
|
| | * CPT deficiency, hepatic, type II - CPT2 | | * Hypoglycemia hypoketonic related to carnitine palmitoyltransferase II - CPTase | | * Myopathy due to CPT II deficiency - CPT2 |
|
Primary systemic carnitine deficiency - (AR) | 9.19 | | | Solute carrier family 22 member 5
|
|
| | * Carnitine deficiency, systemic primary - CDSP |
|
Carnitine acylcarnitine translocase deficiency - (AR) | 9.20 | | | Carnitine-acylcarnitine translocase(M)
|
|
| | * Carnitine-acylcarnitine translocase deficiency - CACT |
|
Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIA - (AR) | 9.21 | | | Electron-transfer-flavoprotein, alpha polypeptide(M)
|
|
| | * Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIA) - GAIIA |
|
Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIB) - (AR) | 9.22 | | | Electron-transfer-flavoprotein, beta polypeptide(M)
|
|
| | * Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIB) - GAIIB |
|
Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIC) - (AR) | 9.23 | | | Electron-transferring-flavoprotein dehydrogenase(M)
|
|
| | * Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIC) - GAIIC | | * Multiple acyl-coa dehydrogenase deficiency - MADD |
|
Acyl-CoA dehydrogenase (very long chain) deficiency (VLCAD deficiency) - (AR) | 9.24 | | | Acyl-Coenzyme A dehydrogenase, very long chain(M)
|
|
| | * Acyl-CoA dehydrogenase (very long chain) deficiency - VLCAD |
|
Mitochondrial complex I deficiency due to ACAD9 deficiency - (AR) | 9.25 | | | Acyl-CoA dehydrogenase family member 9(M)
|
|
| | * Mitochondrial complex 1 deficiency, nuclear type 20 - MC1DN20 |
|
Triglyceride storage disease with impaired long-chain fatty acid oxidation (Chanarin-Dorfman syndrome) - (AR) | 9.26 | | | Abhydrolase domain containing 5
|
|
| | * Chanarin-Dorfman syndrome - CDS |
|
Neutral lipid storage disease with myopathy without ichthyosis - (AR) | 9.27 | | | Adipose triglyceride lipase (desnutrin)
|
|
| | * Neutral lipid storage disease without ichthyosis - NLSDM |
|
Acute Recurrent myoglobinuria - (AR) | 9.28 | | | Lipin 1 (phosphatidic acid phosphatase 1)
|
|
| | * Reccurrent myoglobinuria, autosomal recessive |
|
Mitochondrial myopathy with lactic acidosis - (AR) | 9.29 | | | Patatin-like phospholipase domain containing 8(M)
|
|
| | * Infantile neuroaxonal dystrophy and neutral lipid storage disease with myopathy - MMLA |
|
Lipid storage myopathy due to Flavin Adenine Dinucleotide Synthetase Deficiency - (AR) | 9.30 | | | flavin adenine dinucleotide synthetase, homolog(M)
|
|
| | * Lipid storage myopathy due to Flavin Adenine Dinucleotide Synthetase Deficiency - LSMFLAD |
|